Drug Development for Neurodegenerative Diseases

23 Apr 2009

Boston: Drug Development Strategies for Neuro Diseases Drug Development for Neurodegenerative Diseases

Strategic Research Institute’s Alzheimer Disease Conference

06 May 2008

Boston: Neuroprotective Peptide Inches Forward in Clinic Strategic Research Institute’s Alzheimer Disease Conference

Measures of Clinical Meaningfulness—An AD Ally/FDA Scientific Workshop

31 Mar 2008

Alzheimer Activism: How To Modernize Clinical Trials? Measures of Clinical Meaningfulness—An AD Ally/FDA Scientific Workshop

Neurobiology of Aging 2004

20 Dec 2004

Conformation Rules Part 1: News, Common Threads, Debate from San Diego Conference Conformation Rules Part 2: News, Common Threads, Debate from San Diego Protein Misfolding Conference Conformation Rules Part 3: News, Common Threads, Debate from San Diego P

Alzheimer 100 Centennial

16 Nov 2006

Tuebingen: Researchers Reminisce, Predict at Alzheimer Centennial Tuebingen: The Man Behind the Eponym Alzheimer 100 Centennial

American Neurological Association: 2002 Annual Meeting

14 Feb 2003

American Neurological Association Annual Meeting: Biomarkers and Mitochondrial Therapy American Neurological Association: 2002 Annual Meeting

Keystone Symposium: Alzheimer's Disease 2008

21 Apr 2006

Keystone Drug News: CoMentis BACE Inhibitor Debuts Keystone Drug News: Agonists for M1, Serotonin Receptors Prime Cholinergic Pump Keystone Drug News: Phase 2 Anti-oligomer Sugar Alcohol—How Might It Work? Keystone Drug News: Glimpse of Lilly’s Phase 1 Pa

Memory Disorders Research Society

03 Nov 2003

Mark A. Gluck and Paul Reber Report on Memory Disorders Meeting Memory Disorders Research Society

Institute for the Study of Aging Symposium

20 Jul 2003

PET Diagnosis Poised for Prime Time? FDA Wants Consensus, Better Trials ApoE Catalyst Conference Explores Drug Development Opportunities Institute for the Study of Aging Symposium

Dominantly Inherited Alzheimer Network Pharma Consortium Meeting 2013

25 Apr 2013

As DIAN’s Scope Widens, Funding Narrows Dominantly Inherited Alzheimer Network Pharma Consortium Meeting 2013

ApoE, ApoE Receptors & Neurodegeneration, 2011

26 Jul 2011

Chicago: 2nd Annual Symposium Explores ApoE ApoE, ApoE Receptors & Neurodegeneration, 2011

European Federation of Neurological Societies

12 Sep 2012

Bapineuzumab Phase 3: Target Engagement, But No Benefit European Federation of Neurological Societies

Beijing Symposium on Aging and Neurodegeneration

06 Nov 2008

Beijing: Report From Symposium on Aging and Neurodegeneration Beijing Symposium on Aging and Neurodegeneration

Ipsen Colloquium on Alzheimer’s Disease 2007

07 Jul 2007

Paris: Synaptic Plasticity and the Mechanism of Alzheimer Disease Ipsen Colloquium on Alzheimer’s Disease 2007

Ipsen Colloquium on Alzheimer’s Disease 2008

03 Jul 2008

Paris: Intracellular Traffic and Neurodegenerative Disorders Ipsen Colloquium on Alzheimer’s Disease 2008